2/3 March 2022
The European GDP Association has recently announced a change in the Board. Emil Schwan moves from the Board to the Authority Advisory Board, of which he was already a member from 2017 until May 2020.
The Authority Advisory Board Members support the GDP Working Group on a case by case decision and not for all of its activities.
Emil Schwan is a pharmacist with experience from performing GMP and GDP inspections, formulation development, manufacturing of medicinal products and pharmaceutical quality systems. Emil has been chief designer for medicinal products of several dosage forms. Emil comes from the Swedish Medical Products Agency (MPA), where he spent eight years as a pharmaceutical inspector. As an inspector he inspected sites in Sweden and in countries outside the EU, e.g. China, India, USA. He has knowledge in GMP and GDP for both medicinal products and active pharmaceutical substances. After working as a Senior Consultant for RegSmart Life Science AB, he returned as an inspector with the MPA in November 2021.
Find out more about the European GDP Association Board of Directors and the Authority Advisory Board.